Funding for this research was provided by:
Versus Arthritis (20777)
Received: 10 July 2020
Accepted: 6 January 2021
First Online: 19 January 2021
Ethics approval and consent to participate
: The OAI study was approved by the Institutional Review Board of the University of California, San Francisco, and its affiliates. All participants gave written informed consent.
: All authors agreed to the publication of this manuscript.
: D.A. Walsh: Grants from Versus Arthritis, while the study was being conducted; grants from Pfizer Ltd., other from Pfizer Ltd., personal fees from GlaxoSmithKline, outside the submitted work.D. F. McWilliams: grants from Pfizer Ltd.The remaining authors have no conflicts of interest to declare.